HOFBF
Price
$0.15
Change
+$0.06 (+60.00%)
Updated
Apr 14 closing price
Capitalization
82.79M
INNMF
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Capitalization
16.62M
Interact to see
Advertisement

HOFBF vs INNMF

Header iconHOFBF vs INNMF Comparison
Open Charts HOFBF vs INNMFBanner chart's image
Hofseth Biocare ASA
Price$0.15
Change+$0.06 (+60.00%)
Volume$400
Capitalization82.79M
Amplia Therapeutics
Price$0.04
Change-$0.00 (-0.00%)
Volume$130K
Capitalization16.62M
HOFBF vs INNMF Comparison Chart
Loading...
View a ticker or compare two or three
VS
HOFBF vs. INNMF commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOFBF is a Hold and INNMF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (HOFBF: $0.16 vs. INNMF: $0.04)
Brand notoriety: HOFBF and INNMF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOFBF: 9% vs. INNMF: 311%
Market capitalization -- HOFBF: $82.79M vs. INNMF: $16.62M
HOFBF [@Biotechnology] is valued at $82.79M. INNMF’s [@Biotechnology] market capitalization is $16.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOFBF’s FA Score shows that 0 FA rating(s) are green whileINNMF’s FA Score has 1 green FA rating(s).

  • HOFBF’s FA Score: 0 green, 5 red.
  • INNMF’s FA Score: 1 green, 4 red.
According to our system of comparison, INNMF is a better buy in the long-term than HOFBF.

Price Growth

HOFBF (@Biotechnology) experienced а 0.00% price change this week, while INNMF (@Biotechnology) price change was +4.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.92%. For the same industry, the average monthly price growth was +17.56%, and the average quarterly price growth was +3.51%.

Industries' Descriptions

@Biotechnology (+11.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
HOFBF($82.8M) has a higher market cap than INNMF($16.6M). HOFBF YTD gains are higher at: 55.000 vs. INNMF (-5.327). INNMF has higher annual earnings (EBITDA): -6.01M vs. HOFBF (-67.94M).
HOFBFINNMFHOFBF / INNMF
Capitalization82.8M16.6M499%
EBITDA-67.94M-6.01M1,130%
Gain YTD55.000-5.327-1,032%
P/E RatioN/AN/A-
Revenue257MN/A-
Total Cash25.6MN/A-
Total Debt171MN/A-
FUNDAMENTALS RATINGS
HOFBF vs INNMF: Fundamental Ratings
HOFBF
INNMF
OUTLOOK RATING
1..100
3045
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9894
PRICE GROWTH RATING
1..100
4063
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INNMF's Valuation (20) in the null industry is somewhat better than the same rating for HOFBF (78). This means that INNMF’s stock grew somewhat faster than HOFBF’s over the last 12 months.

INNMF's Profit vs Risk Rating (100) in the null industry is in the same range as HOFBF (100). This means that INNMF’s stock grew similarly to HOFBF’s over the last 12 months.

INNMF's SMR Rating (94) in the null industry is in the same range as HOFBF (98). This means that INNMF’s stock grew similarly to HOFBF’s over the last 12 months.

HOFBF's Price Growth Rating (40) in the null industry is in the same range as INNMF (63). This means that HOFBF’s stock grew similarly to INNMF’s over the last 12 months.

HOFBF's P/E Growth Rating (100) in the null industry is in the same range as INNMF (100). This means that HOFBF’s stock grew similarly to INNMF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DMF6.990.03
+0.43%
BNY Mellon Municipal Income
CNYNZD0.23N/A
N/A
China Yuan - New Zealand Dollar
CADEUR0.64N/A
N/A
Canadian Dollar - Euro
HYDB46.59-0.12
-0.26%
iShares High Yield Systematic Bond ETF
EWJV34.82-0.42
-1.19%
iShares MSCI Japan Value ETF

HOFBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOFBF has been loosely correlated with BIVI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if HOFBF jumps, then BIVI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOFBF
1D Price
Change %
HOFBF100%
N/A
BIVI - HOFBF
44%
Loosely correlated
-0.46%
ETXPF - HOFBF
38%
Loosely correlated
N/A
PHGE - HOFBF
35%
Loosely correlated
-4.48%
INNMF - HOFBF
23%
Poorly correlated
N/A
IGXT - HOFBF
14%
Poorly correlated
N/A
More

INNMF and

Correlation & Price change

A.I.dvisor tells us that INNMF and BIVI have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INNMF and BIVI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INNMF
1D Price
Change %
INNMF100%
N/A
BIVI - INNMF
26%
Poorly correlated
-0.46%
HOFBF - INNMF
23%
Poorly correlated
N/A
CYTK - INNMF
23%
Poorly correlated
-1.02%
PHRRF - INNMF
20%
Poorly correlated
-3.23%
IVEVF - INNMF
15%
Poorly correlated
N/A
More